<DOC>
	<DOCNO>NCT01277536</DOCNO>
	<brief_summary>Until , risk assessment model inform need thromboprophylaxis patient admit acute medical event validate . The goal project indirectly validate model develop Geneva non -interventional study involve collection patient characteristic hospitalization 3-month follow-up . These data allow determination patient 's risk , accord Geneva model , validity , accord actual thrombo-embolic event , correct thromboprophylaxis receive . The project multicentric Switzerland ( 5-10 center ) involve 1000 patient . First amendment ( may 2011 ) : obtain IRB approval collect data patient die hospital stay inform consent possible obtain .</brief_summary>
	<brief_title>Explicit Assessment Thromboembolic Risk Prophylaxis Medical Patients Switzerland</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<criteria>Patients admit ( minimal stay &gt; 24 hour ) medical hospital ward Age â‰¥18 year Ability give inform consent , informed physician charge patient Patients admit nonmedical hospital ward Patients therapeutic anticoagulation hospital admission Patients admit disease require therapeutic anticoagulation ( MTE ) Patients unable give inform consent , informed physician charge patient Patients without sign informed consent Patients already include study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>